Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Clean the slate please

< This will be a far better investment than previous uses of MMP Portfolio License Fees>

You might well be right. But for now we live or die with the MMP. PTSC has to do whatever is necessary to insure MMP continues to move forward at PTO, at court and at thre bargaining table. If this requires that we help TPL, we have to do it. I think most would agree with the above, no matter how distasteful helping Leckrone might be.

But then why this?

<<We do not anticipate making additional loans to TPL, and its ability to access liquidity from other sources is not certain.>>

Don't anticipate because they will not need additional loans? If so, why make a point of the potential difficulty in accessing liquidity elsewhere?

Is PTSC saying we helped TPL to the extent we believe is reasonable and, if we have to do more, it's going to cost them dearly? What exactly is being said here? How do others read it?

Opty

Share
New Message
Please login to post a reply